New pill shows promise for Hard-to-Treat cancers
NCT ID NCT06898450
First seen Nov 18, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This early-stage trial tests a new daily pill, NDI-219216, in 134 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, side effects, and whether the drug can shrink tumors. Participants take the pill daily, visit the clinic regularly, and keep a symptom diary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist Center
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact
-
Brown University Health
RECRUITINGProvidence, Rhode Island, 02901, United States
Contact
-
Cayuga Cancer Center
TERMINATEDIthaca, New York, 14850, United States
-
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITINGPoitiers, 86021, France
Contact
-
Hospital Clinico San Carlos
RECRUITINGMadrid, 28040, Spain
Contact
-
Hôpital Saint-Antoine - Assistance Publique-Hopitaux de Paris (AP-HP)
RECRUITINGParis, 75012, France
Contact
-
Levine Cancer Center
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
-
Liverpool Hospital
RECRUITINGLiverpool, New South Wales, 2170, Australia
Contact
-
Princess Margaret Cancer Center
RECRUITINGToronto, Ontario, M5G2C4, Canada
Contact
-
Prisma Health Cancer Institute - Multidisciplinary Center
RECRUITINGGreenville, South Carolina, 29605, United States
Contact
-
START Barcelona
RECRUITINGBarcelona, 08023, Spain
Contact
-
START Dublin
RECRUITINGDublin, D07 R2WY, Ireland
Contact
-
START Lisbon
RECRUITINGLisbon, 1649-028, Portugal
Contact
-
Sarah Cannon Research Institute UK
RECRUITINGLondon, W1G 6AD, United Kingdom
Contact
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
Contact
-
Taylor Cancer Research Center
RECRUITINGMaumee, Ohio, 43537, United States
Contact
-
The Christie NHS Foundation Trust UK
RECRUITINGManchester, M20 4BX, United Kingdom
Contact
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90089, United States
Contact
-
University of Chicago Medicine
RECRUITINGChicago, Illinois, 60637, United States
Contact
-
University of Louisville James Graham Brown Cancer Center
RECRUITINGLouisville, Kentucky, 40202, United States
Contact
-
University of Virginia Emily Couric Clinical Cancer Center
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact
-
Virginia Cancer Specialists, P.C. - Fairfax
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Conditions
Explore the condition pages connected to this study.